Exenatide protects against hypoxia/reoxygenation-induced apoptosis by improving mitochondrial function in H9c2 cells

Experimental Biology and Medicine

Volumn 239, Issue 4, 2014, Pages 414-422

  Chang, Guanglei ^a   Zhang, Dongying ^a   Liu, Jian ^a   Zhang, Peng ^a   Ye, Lin ^a   Lu, Kai ^a   Duan, Qin ^a   Zheng, Aihua ^a   Qin, Shu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

cardiomyocyte apoptosis; exenatide; GLP 1 analogue; hypoxia reoxygenation; mitochondria

Indexed keywords

CARDIOMYOCYTE APOPTOSIS; EXENATIDE; GLP-1 ANALOGUE; HYPOXIA/REOXYGENATION; MITOCHONDRIA;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CELL HYPOXIA; CELL LINE; CYTOCHROMES C; FLOW CYTOMETRY; GLUCAGON-LIKE PEPTIDE 1; MALONDIALDEHYDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PEPTIDES; RATS; SUPEROXIDE DISMUTASE; VENOMS;

EID: 84898935178     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214522177     Document Type: Article

References (45)

1. Pfeffer MA,Braunwald E.Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.Circulation. 1990;81:1161-72.
2. Anversa P,Cheng W,Liu Y,Leri A,Redaell G,Kajstura J.Apoptosis and myocardial infarction.Basic Res Cardiol. 1998;93:8-12.
3. Palojoki E,Saraste A,Eriksson A,Pulkki K,Kallajoki M,Voipio-Pulkki LM,Tikkanen I.Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats.Am J Physiol Heart Circ Physiol. 2001;280:H2726-31.
4. Kajstura J,Cheng W,Reiss K,Clark WA,Sonnenblick EH,Krajewski S,Reed JC,Olivetti G,Anversa P.Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.Lab Invest. 1996;4:86-107.
5. Saraste A,Pulkki K,Kallajoki M,Henriksen K,Parvinen M,Voipio-Pulkki LM.Apoptosis in human acute myocardial infarction.Circulation. 1997;95:320-3.
6. Regula KM,Kirshenbaum LA.Apoptosis of ventricular myocytes: a means to an end.J Mol Cell Cardiol. 2005;38:3-13.
7. Lee Y,Gustafsson AB.Role of apoptosis in cardiovascular disease.Apoptosis. 2009;14:536-48.
8. Favaloro B,Allocati N,Graziano V,Di Ilio C,De Laurenzi V.Role of apoptosis in disease.Aging (Albany NY). 2012;4:330-49.
9. Crow MT,Mani K,Nam YJ,Kitsis RN.The mitochondrial death pathway and cardiac myocyte apoptosis.Circ Res. 2004;95:957-70.
10. Danial NN,Korsmeyer SJ.Cell death: critical control points.Cell. 2004;116:205-19.
11. Sarkey JP,Chu M,McShane M,Bovo E,Mou YA,Zima AV,de Tombe PP,Kartje GL,Martin JL.Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes.J Mol Cell Cardiol. 2011;50:1044-55.
12. Li Q,Zhou LY,Gao GF,Jiao JQ,Li PF.Mitochondrial network in the heart.Protein Cell. 2012;3:410-8.
13. Azfer A,Niu J,Rogers LM,Adamski FM,Kolattukudy PE.Activation of endoplasmic reticulum stress response during the development of ischemic heart disease.Am J Physiol Heart Circ Physiol. 2006;291:H1411-20.
14. Minamino T,Kitakaze M.ER stress in cardiovascular disease.J Mol Cell Cardiol. 2010;48:1105-10.
15. Gorman AM,Healy SJ,Jäger R,Samali A.Stress management at the ER: regulators of ER stress-induced apoptosis.Pharmacol Ther. 2012;134:306-16.
16. Honda HM,Korge P,Weiss JN.Mitochondria and ischemia/reperfusion injury.Ann N Y Acad Sci. 2005;1047:248-58.
17. Chen Q,Moghaddas S,Hoppel CL,Lesnefsky EJ.Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria.Am J Physiol Cell Physiol. 2008;294:C460-6.
18. Zamzami N,Marchetti P,Castedo M,Hirsch T,Susin SA,Masse B,Kroemer G.Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembranepotential during apoptosis.FEBS Lett. 1996;384:53-7.
19. Ylitalo KV,Ala-Rämi A,Liimatta EV,Peuhkurinen KJ,Hassinen IE.Intracellular free calcium and mitochondrial membrane potential in ischemia/reperfusion and preconditioning.J Mol Cell Cardiol. 2000;32:1223-38.
20. Shintani-Ishida K,Inui M,Yoshida K.Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca2+ overload.J Mol Cell Cardiol. 2012;53:233-9.
21. Hausenloy DJ,Yellon DM,Mani-Babu S,Duchen MR.Preconditioning protects by inhibiting the mitochondrial permeability transition.Am J Physiol Heart Circ Physiol. 2004;287:H841-9.
22. Hoshovs'ka IuV,Shymans'ka TV,Rudyk OV,Korkach IuP,Sahach VF.Mitochondria permeability transition as a target for ischemic preconditioning.Fiziol Zh. 2011;57:34-45.
23. Lundberg KC,Szweda LI.Preconditioning prevents loss in mitochondrial function and release of cytochrome c during prolonged cardiac ischemia/reperfusion.Arch Biochem Biophys. 2006;453:130-4.
24. Garber AJ.Novel GLP-1 receptor agonists for diabetes.Expert Opin Investig Drugs. 2012;21:45-57.
25. Timmers L,Henriques JP,de Kleijn DP,Devries JH,Kemperman H,Steendijk P,Verlaan CW,Kerver M,Piek JJ,Doevendans PA,Pasterkamp G,Hoefer IE.Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.J Am Coll Cardiol. 2009;53:501-10.
26. Chiquette E,Toth PP,Ramirez G,Cobble M,Chilton R.Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers.Vasc Health Risk Manag. 2012;8:621-9.
27. Xie Y,Wang SX,Sha WW,Zhou X,Wang WL,Han LP,Li DQ,Yu DM.Effects and mechanism of glucagon-like peptide-1 on injury of rats cardiomyocytes induced by hypoxia-reoxygenation.Chin Med J (Engl). 2008;121:2134-8.
28. Ravassa S,Zudaire A,Carr RD,Díez J.Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes.Am J Physiol Heart Circ Physiol. 2011;300:H1361-72.
29. Ravassa S,Zudaire A,Díez J.Glucagon-like peptide 1 and cardiac cell survival.Endocrinol Nutr. 2012;59:561-9.
30. Wright EJ,Farrell KA,Malik N,Kassem M,Lewis AL,Wallrapp C,Holt CM.Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a beneficial effect on failing pig hearts.Stem Cells Transl Med. 2012;1:759-69.
31. Park M,Youn B,Zheng XL,Wu D,Xu A,Sweeney G.Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis.PloS One. 2011;6:e19143-e19143.
32. Wang L,Wang ZH,Shen CY,You ML,Xiao JF,Chen GQ.Differentiation of human bone marrow mesenchymal stem cells grown in terpolyesters of 3-hydroxyalkanoates scaffolds into nerve cells.Biomaterials. 2010;31:1691-8.
33. Kumar S,Kain V,Sitasawad SL.High glucose-induced Ca2+ overload and oxidative stress contribute to apoptosis of cardiac cells through mitochondrial dependent and independent pathways.Biochim Biophys Acta. 2012;1820:907-20.
34. Odagiri K,Katoh H,Kawashima H,Tanaka T,Ohtani H,Saotome M,Urushida T,Satoh H,Hayashi H.Local control of mitochondrial membrane potential, permeability transition pore and reactive oxygen species by calcium and calmodulin in rat ventricular myocytes.J Mol Cell Cardiol. 2009;46:989-97.
35. Yue R,Hu H,Yiu KH,Luo T,Zhou Z,Xu L,Zhang S,Li K,Yu Z.Lycopene protects against hypoxia/reoxygenation - induced apoptosis by preventing mitochondrial dysfunction in primary neonatal mouse cardiomyocytes.PloS One. 2012;7:e50778-e50778.
36. Poyton RO,Ball KA,Castello PR.Mitochondrial generation of free radicals and hypoxic signaling.Trends Endocrinol Metab. 2009;20:332-40.
37. Becker LB,vandenHoek TL,Shao ZH,Li CQ,Schumacker PT.Generation of superoxide in cardiomyocytes during ischemia before reperfusion.Am J Physiol. 1999;277:H2240-6.
38. Becker LB.New concepts in reactive oxygen species and cardiovascular reperfusion physiology.Cardiovasc Res. 2004;61:461-70.
39. Chen Q,Vazquez EJ,Moghaddas S,Hoppel CL,Lesnefsky EJ.Production of reactive oxygen species by mitochondria.J Biol Chem. 2003;278:36027-31.
40. Cortassa S,Aon MA,Winslow RL,O'Rourke B.A mitochondrial oscillator dependent on reactive oxygen species.Biophys J. 2004;87:2060-73.
41. Ott M,Gogvadze V,Orrenius S,Zhivotovsky B.Mitochondria, oxidative stress and cell death.Apoptosis. 2007;12:913-22.
42. Weiss JN,Korge P,Honda HM,Ping P.Role of the mitochondrial permeability transition in myocardial disease.Circ Res. 2003;93:292-301.
43. Patterson SD,Spahr CS,Daugas E,Susin SA,Irinopoulou T,Koehler C,Kroemer G.Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition.Cell Death Differ. 2000;7:137-44.
44. Galluzzi L,Morselli E,Kepp O,Kroemer G.Targeting post mitochondrial effectors of apoptosis for neuroprotection.Biochim Biophys Acta. 2009;1787:402-13.
45. Wei Q,Sun YQ,Zhang J.Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.Peptides. 2012;37:18-24.